Noven Pharmaceuticals, in partnership with Shire plc, is developing a new transdermal patch for the treatment of ADHD. The two companies previously worked together to develop Daytrana™, which was the first ADHD treatment patch ever approved.

"As previously announced, Noven successfully completed a Phase 1 study of an amphetamine transdermal system (ATS) under development for the treatment of ADHD. Shire has requested modifications to the original patch formulation in order to align ATS with its future direction in ADHD."

Daytrana™ was first released in June 2006. It was the first, and is currently the only, transdermal product approved for ADHD therapy.

The new school year is just around the corner - now's the time to look into finding an ADHD school or Asperger's Schools or a school for children with a non-verbal learning disorder. Cedars Academy is a private school specializing in children with ADD, ADHD, NLD, or Asperger's.

Labels: medications, treatment, therapy

Posted By: Aspen Education Group